Thread by @WHO

The 🆕 WHO report on global access to #insulin shows how a century after its discovery, insulin remains inaccessible or unaffordable for many children and adults living with #diabetes around the 🌍🌎🌏.

More here 👉bit.ly/3c2ADZY

5 out of 10 people with type 2 #diabetes in the 🌍 still do not have access to insulin and only 3 companies dominate 90% of the market for insulin setting 📈 prices.

This is unacceptable. Everybody deserves to have access to life-saving treatment.

bit.ly/3c2ADZY

WHO is hosting dialogues with manufacturers to increase availability of #insulin and other diabetes medicines and health technologies under the framework of the Global Diabetes Compact.

bit.ly/3c2ADZY

Commitments made by manufacturers of #diabetes medicines and technologies so far include:

✅ Participation in WHO prequalification programme.
✅ Participation in pooled procurement mechanism when established.

Further commitments needed.
bit.ly/3c2ADZY

Analogue #insulin is at least 1.5 times more expensive than human insulins.

People living in low- and middle-income countries can spend up to 2⃣ weeks of their wages on buying only 1⃣ month’s supply of analogues.

bit.ly/3c2ADZY

#Insulin can be produced at a relatively low cost - between US$ 2 and US$ 25 for a month’s supply, yet prices to patients could be more than US$ 80.

bit.ly/3c2ADZY

80% of the patients living with #diabetes are in low- and middle-income countries, yet the research on treatments is geared towards wealthy markets neglecting those who need them most.

bit.ly/3c2ADZY

To increase access to insulin WHO advises to:

1⃣ Boost human insulin supply and diversify the manufacture of analogue insulins.
2⃣ Ensure that prompt diagnosis and access to devices for 🩸 sugar monitoring and 💉 insulin are available.
3⃣ Use human insulin where possible.

If you are living with diabetes and control your blood glucose levels with insulin daily you can live a full life, enjoy sport, social activities, family, and more! 💪

bit.ly/3c2ADZY